期刊文献+

采用Cox回归描述多变量生存期和预测多变量生存率 被引量:3

Description of Multivariate Survival Period and Prediction of Multivariate Survival Rate with Cox Regression
暂未订购
导出
摘要 目的 采用Cox回归描述多变量生存期和预测多变量生存率。方法 介绍生存函数和结合线性内插法的基本原理 ,用一个实例和SPSS 8 0的Coxregression过程说明该计算方法。结果 列出该法和Kaplan -Meier法的比较表和预测某个体的多变量生存率。结论 涉及多变量影响的生存分析时 ,使用该法进行描述和预测更客观和直观。 Objectives To introduce the description of multivaiate survival period and prediction of multivariate survival rate with Cox regression.Methods Basic principles of survival function and linear inerpolation are introduced.The methods are illustrated by an example and the Cox regression procedure of SPSS 8 0.Results The table of comparison between survival period at mean of two covariates and Kaplan-Meier's and prediction of a case's survival rate are shown.Conclusion When is made the survival analysis involving in multivariates,it is objective and directive to use the method to make description and prediction.
出处 《中国公共卫生》 CAS CSCD 北大核心 2001年第6期561-562,共2页 Chinese Journal of Public Health
关键词 COX回归 描述 预测 生存分析 多变量 生存率 Cox regression description and prediction survival analysis
  • 相关文献

参考文献5

二级参考文献12

  • 1王冬,临床放射学杂志,1995年,14卷,220页
  • 2韩要法,肿瘤,1995年,15卷,406页
  • 3魏金芝,实用癌症杂志,1993年,8卷,175页
  • 4陈易人,实用外科杂志,1991年,11卷,437页
  • 5王维冬,肿瘤,1990年,10卷,44页
  • 6郑裕隆,实用癌症杂志,1989年,4卷,138页
  • 7Tang Z Y,Gan To Kagaku Ryoho,1997年,24Suppl1Suppl1期,126页
  • 8He B,J Cancer Res Clin Oncol,1996年,122页
  • 9Tang Z Y,J Gastroenterol Hepatol,1995年,10卷,683页
  • 10Barry S. Mitchell,A. Whitehouse,P. Prehm,B. Delpech,Udo Schumacher. CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation[J] 1996,Clinical & Experimental Metastasis(2):107~114

共引文献72

同被引文献27

  • 1曹卫华,李福玲,郭英,惠宗光,李琰琳.糖尿病风险评分与糖调节受损的相关性研究[J].护理研究(上旬版),2007,21(8):1995-1997. 被引量:6
  • 2Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl, 2002, 8 : 851-858.
  • 3Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31:864-871.
  • 4De Carlis L, Giacomoni A, Pirotta V, et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coil Surg, 2003, 196 : 887-897.
  • 5Ochiai T, Sonoyama T, Ichikawa D, et al. Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol, 2004, 130: 197-202.
  • 6Del Gaudio M, Grazi GL, Principe A, et al. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis:a univariate and multivariate analysis. Hepatogastroenterology, 2004, 51:510-514.
  • 7Heuman DM, Abou-Assi SG, Habib A,et al. Persistent ascites and low serum sodium identify patient s with cirrhosis and low MELD scores who are at high risk for early death. Hepatology, 2004,40 : 802-810.
  • 8Big, gins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, 2005,41:32-39.
  • 9Ruf AE, Kremers WK, Chzvez LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl, 2005, 11:336-343.
  • 10Bismuth H, Majno PE, Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis, 1999, 19 : 311-322.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部